Pulike Biological Engineering, Inc. (603566.SS)
CNY 12.25
(0.41%)
CNY 12.25
(0.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 538.33 Million CNY | -8.46% |
| 2022 | 588.06 Million CNY | 59.88% |
| 2021 | 367.82 Million CNY | 15.25% |
| 2020 | 319.15 Million CNY | 29.0% |
| 2019 | 247.41 Million CNY | -7.51% |
| 2018 | 267.5 Million CNY | 13.22% |
| 2017 | 236.27 Million CNY | -7.67% |
| 2016 | 255.9 Million CNY | 53.71% |
| 2015 | 166.49 Million CNY | 8.01% |
| 2014 | 154.13 Million CNY | 21.04% |
| 2013 | 127.34 Million CNY | -10.1% |
| 2012 | 141.66 Million CNY | -25.17% |
| 2011 | 189.3 Million CNY | -22.94% |
| 2010 | 245.65 Million CNY | 218.22% |
| 2009 | 77.19 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 451.58 Million CNY | -6.59% |
| 2024 Q1 | 471.72 Million CNY | -12.37% |
| 2024 Q2 | 483.46 Million CNY | 2.49% |
| 2023 Q4 | 538.33 Million CNY | -11.9% |
| 2023 Q1 | 519.01 Million CNY | -11.74% |
| 2023 FY | 538.33 Million CNY | -8.46% |
| 2023 Q3 | 611.02 Million CNY | 14.19% |
| 2023 Q2 | 535.11 Million CNY | 3.1% |
| 2022 Q1 | 406 Million CNY | 10.38% |
| 2022 Q4 | 588.06 Million CNY | 16.17% |
| 2022 FY | 588.06 Million CNY | 59.88% |
| 2022 Q3 | 506.2 Million CNY | 5.87% |
| 2022 Q2 | 478.13 Million CNY | 17.76% |
| 2021 Q1 | 320.95 Million CNY | 0.56% |
| 2021 Q3 | 337.16 Million CNY | -2.28% |
| 2021 Q2 | 345.03 Million CNY | 7.5% |
| 2021 Q4 | 367.82 Million CNY | 9.09% |
| 2021 FY | 367.82 Million CNY | 15.25% |
| 2020 Q4 | 319.15 Million CNY | 25.25% |
| 2020 FY | 319.15 Million CNY | 29.0% |
| 2020 Q2 | 231.27 Million CNY | 1.22% |
| 2020 Q3 | 254.8 Million CNY | 10.18% |
| 2020 Q1 | 228.48 Million CNY | -7.65% |
| 2019 Q4 | 247.41 Million CNY | 24.15% |
| 2019 Q1 | 233.14 Million CNY | -12.85% |
| 2019 Q2 | 216.27 Million CNY | -7.24% |
| 2019 Q3 | 199.28 Million CNY | -7.85% |
| 2019 FY | 247.41 Million CNY | -7.51% |
| 2018 Q1 | 228.58 Million CNY | -3.25% |
| 2018 FY | 267.5 Million CNY | 13.22% |
| 2018 Q4 | 267.5 Million CNY | 15.76% |
| 2018 Q3 | 231.08 Million CNY | -0.72% |
| 2018 Q2 | 232.76 Million CNY | 1.83% |
| 2017 Q2 | 238.01 Million CNY | -0.47% |
| 2017 Q3 | 243.88 Million CNY | 2.46% |
| 2017 Q4 | 236.27 Million CNY | -3.12% |
| 2017 FY | 236.27 Million CNY | -7.67% |
| 2017 Q1 | 239.14 Million CNY | -6.55% |
| 2016 Q2 | 158.62 Million CNY | -3.36% |
| 2016 Q1 | 164.15 Million CNY | -1.41% |
| 2016 Q4 | 255.9 Million CNY | 62.93% |
| 2016 Q3 | 157.06 Million CNY | -0.98% |
| 2016 FY | 255.9 Million CNY | 53.71% |
| 2015 Q1 | 160.68 Million CNY | 4.25% |
| 2015 Q4 | 166.49 Million CNY | 3.25% |
| 2015 Q3 | 161.24 Million CNY | 8.94% |
| 2015 Q2 | 148.01 Million CNY | -7.88% |
| 2015 FY | 166.49 Million CNY | 8.01% |
| 2014 Q4 | 154.13 Million CNY | 0.0% |
| 2014 FY | 154.13 Million CNY | 21.04% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 FY | 127.34 Million CNY | -10.1% |
| 2012 FY | 141.66 Million CNY | -25.17% |
| 2011 FY | 189.3 Million CNY | -22.94% |
| 2010 FY | 245.65 Million CNY | 218.22% |
| 2009 FY | 77.19 Million CNY | 0.0% |